MK

Mukesh Kumar Gupta

Active Director Director DIN 07258281
DIN 07258281 First appointment Aug 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2015
Shareholding value •••• Premium profile

About Mukesh Kumar Gupta

Data last updated:

Mukesh Kumar Gupta is a Director at Safron Pharmaceuticals Private Limited (since 2015). The company operates in Healthcare. Safron Pharmaceuticals Private Limited reported revenue of ₹1.28 Cr (FY 2024).

DIN 07258281
Primary Designation Director
Industry Healthcare
First Appointment 07 Aug 2015
Oldest Company Age 15 yrs
Largest company Safron Pharmaceuticals Private Limited · ₹1.28 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Aug 20152010₹1.28 Cr (FY 2024)Active

Directorship timeline

Open interactive timeline →
Safron Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mukesh Kumar Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mukesh Kumar Gupta

Mukesh Kumar Gupta currently holds 1 directorship: Safron Pharmaceuticals Private Limited (Director, since 07 Aug 2015, revenue ₹1.28 Cr (FY 2024)).

Mukesh Kumar Gupta was first appointed on 07 Aug 2015 as Director at Safron Pharmaceuticals Private Limited.

The current boards of Mukesh Kumar Gupta's companies include Mahesh Chand Gupta (Safron Pharmaceuticals Private Limited), Manish Mittal (Safron Pharmaceuticals Private Limited), Rohit Singhal (Safron Pharmaceuticals Private Limited), Sanju Vijay (Safron Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available